サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1404818

腫瘍学に基づく分子診断市場規模、シェア、動向分析レポート：タイプ別、製品別、技術別、地域別、セグメント別予測、2023年～2030年

Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 139 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
腫瘍学に基づく分子診断市場規模、シェア、動向分析レポート：タイプ別、製品別、技術別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年11月29日
発行: Grand View Research
ページ情報: 英文 139 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腫瘍学に基づく分子診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、腫瘍学に基づく分子診断の世界市場規模は、2023年から2030年にかけて12.1％のCAGRを記録し、2030年までに60億米ドルに達すると予測されています。

高齢者人口の増加、世界のがん有病率の増加、座りがちなライフスタイルの普及レベルの上昇、意識向上と患者教育が、予測期間中の腫瘍学に基づく分子診断市場成長の原動力です。

座りがちなライフスタイルの定着や免疫力の低下に起因するがん患者の増加は、産業成長率を高めると推定されます。さらに、ブラジル、メキシコ、南アフリカ、インドなどの新興諸国では、がん罹患率および死亡率に大きなばらつきがあることから、早期発見と検証によって生存率を高めるために分子診断薬の利用が促進されると予測されます。

腫瘍学に基づく分子診断市場レポートハイライト

  • 乳がんは、検査量の多さと商品化された製品の豊富なポートフォリオにより、2022年の収益シェアで市場全体を支配。
  • 大腸がんは、miRNAマイクロアレイのような技術的に進歩したマイクロアレイやアッセイの利用可能性により、予測期間中に有利な成長を示すと推定・予測されます。
  • 製品別では、試薬セグメントが2022年の全体収益のほぼ58.0%で最も高いシェアを占めました。この分野では、医薬品開発を目的とした疾患関連の新規バイオマーカー検出に対する研究者の取り組みが拡大していることが、このセグメントの成長の主な要因であると推定されます。
  • ポリメラーゼ連鎖反応（PCR）技術セグメントは、2022年に31%の最高収益シェアを占めました。これは、研究室での利用が拡大していること、診断強化のニーズが高まっていることに起因しています。
  • シーケンシング分野は予測期間中に14.3%の大幅な成長率が見込まれています。ゲノムデータのハイスループット解析とシークエンシングを提供する次世代シークエンシング技術の発展は、著しい成長の主な促進要因の1つです。
  • 北米は2022年の売上高シェアで40%を超え、市場を独占しました。この地域の力強い市場成長は、確立されたヘルスケアインフラ、絶え間なく上昇する健康志向の人口基盤、高い医療費に起因しています。
  • アジア太平洋地域は、対象人口の多さ、がん発見に対する意識レベルの上昇、同地域における政府イニシアチブの増加により、予測期間中に15.8%のCAGRで最速の成長が見込まれ、最大市場シェアの達成を可能にしています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腫瘍学に基づく分子診断市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随的な市場見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 腫瘍学に基づく分子診断市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 腫瘍学に基づく分子診断市場：タイプの推定・動向分析

  • 腫瘍学に基づく分子診断市場：主要ポイント
  • 腫瘍学に基づく分子診断市場：タイプの動きと市場シェア分析、2022年および2030年
  • 乳がん
    • 乳がん市場推計・予測、2018年～2030年
  • 前立腺がん
    • 前立腺がん市場推計・予測、2018年～2030年
  • 結腸直腸がん
    • 結腸直腸がん市場推計・予測、2018年～2030年
  • 子宮頸がん
    • 子宮頸がん市場推計・予測、2018年～2030年
  • 肝臓がん
    • 肝がん市場推計・予測、2018年～2030年
  • 肺がん
    • 肺がん市場推計・予測、2018年～2030年
  • 血液がん
    • 血液がん市場推計・予測、2018年～2030年
  • 腎臓がん
    • 腎臓がん市場推計・予測、2018年～2030年
  • その他のがん
    • その他のがん市場推計・予測、2018年～2030年

第5章 腫瘍学に基づく分子診断市場：製品推定・動向分析

  • 腫瘍学に基づく分子診断市場：主要ポイント
  • 腫瘍学に基づく分子診断市場：製品動向と市場シェア分析、2022年および2030年
  • 機器
    • 機器市場推計・予測、2018年～2030年
  • 試薬
    • 試薬市場推計・予測、2018年～2030年
  • その他
    • その他の製品の市場推計・予測、2018年～2030年

第6章 腫瘍学に基づく分子診断市場：技術推定・動向分析

  • 腫瘍学に基づく分子診断市場：主要ポイント
  • 腫瘍学に基づく分子診断市場：技術動向と市場シェア分析、2022年および2030年
  • PCR
    • PCR市場推計・予測、2018年～2030年
  • in situハイブリダイゼーション
    • In situハイブリダイゼーション市場推計・予測、2018年～2030年
  • INAAT
    • INAAT市場推計・予測、2018年～2030年
  • チップ・マイクロアレイ
    • チップ・マイクロアレイ市場推計・予測、2018年～2030年
  • 質量分析法
    • 質量分析市場推計・予測、2018年～2030年
  • シーケンス
    • シーケンス市場推計・予測、2018年～2030年
  • TMA
    • TMA市場推計・予測、2018年～2030年
  • その他
    • その他の市場推計・予測、2018年～2030年

第7章 腫瘍学に基づく分子診断市場：地域別の推定・動向分析

  • 地域別の見通し
  • 地域別の腫瘍学に基づく分子診断市場：主要ポイント
  • 北米
    • 市場推計・予測、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Abbott
    • Bayer AG
    • BD
    • Cepheid
    • Agilent Technologies, Inc.
    • Danaher
    • Hologic, Inc.
    • Qiagen
    • F. Hoffmann-La Roche Ltd.
    • Siemens
    • Sysmex
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 3 North America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 North America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 Canada Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 Canada Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 Europe Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 Europe Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Europe Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Europe Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Germany Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Germany Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Germany Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 UK Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 UK Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 UK Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 France Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 France Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 France Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Italy Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Italy Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Italy Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Spain Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Spain Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Spain Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Sweden Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Sweden Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Sweden Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Norway Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Norway Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Norway Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 44 China Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 China Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 46 China Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Japan Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Japan Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Japan Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 India Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 India Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 India Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Thailand Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 Thailand Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Thailand Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 South Korea Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 South Korea Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Australia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Australia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Latin America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Latin America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 66 Brazil Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Brazil Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Brazil Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Mexico Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Mexico Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 UAE Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 86 UAE Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 UAE Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Oncology based molecular diagnostics market: market outlook
  • Fig. 9 Oncology based molecular diagnostics market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Oncology based molecular diagnostics market driver impact
  • Fig. 15 Oncology based molecular diagnostics market restraint impact
  • Fig. 16 Oncology based molecular diagnostics market strategic initiatives analysis
  • Fig. 17 Oncology based molecular diagnostics market: type movement analysis
  • Fig. 18 Oncology based molecular diagnostics market: type outlook and key takeaways
  • Fig. 19 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cervical cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Liver cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Kidney cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Oncology based molecular diagnostics market: product movement analysis
  • Fig. 29 Oncology based molecular diagnostics market: product outlook and key takeaways
  • Fig. 30 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Oncology based molecular diagnostics market: technology movement analysis
  • Fig. 34 Oncology based molecular diagnostics market: technology outlook and key takeaways
  • Fig. 35 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 INAAT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Chips and microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 TMA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global oncology based molecular diagnostics market: regional movement analysis
  • Fig. 44 Global oncology based molecular diagnostics market: regional outlook and key takeaways
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-699-8

Oncology Based Molecular Diagnostics Market Growth & Trends:

The global oncology based molecular diagnostics market size is expected to reach USD 6.00 billion by 2030, registering a CAGR of 12.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population base, increasing global prevalence of cancer, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the oncology based molecular diagnostics market growth over the forecast period.

Growing prevalence of cancer patients owing to adoption of sedentary lifestyles and decrease in immunity levels are estimated to increase industrial growth rate. Furthermore, large variations in both cancer incidence and mortality rates in different sub-regions of developing countries such as Brazil, Mexico, South Africa, and India are also anticipated to enhance the usage of molecular diagnostics to increase survival rates by early detection and validation.

Oncology Based Molecular Diagnostics Market Report Highlights:

  • Breast cancer dominated the overall market in 2022 in terms of revenue share due to large test volumes and an extensive portfolio of commercialized products.
  • Colorectal cancer is estimated to witness lucrative growth over the forecast period owing to the availability of technologically advanced microarrays & assays such as miRNA microarrays.
  • On the basis of product, the reagents segment held the highest share of almost 58.0% of the overall revenue in 2022. Growing initiatives by researchers in this field for detection of disease related novel biomarkers for drug development purpose are estimated to be the key factors attributing to this segment's growth
  • The polymerase chain reaction (PCR) technology segment held the highest revenue share of 31% in 2022. This can be attributed to its growing utilization in research labs and the increased need for enhanced diagnostics.
  • The sequencing segment is anticipated to witness a significant growth rate of 14.3% during the forecast period. Development of next generation sequencing techniques providing high throughput analysis and sequencing of genomic data is one of the key drivers for significant growth.
  • North America dominated the market with a revenue share of over 40% in 2022 The strong market growth in this region can be attributed to a well-established healthcare infrastructure, the constantly rising health-conscious population base, and high healthcare expenditure.
  • Asia Pacific region is expected to advance at the fastest CAGR of 15.8% during the projection period owing to the presence of a large number of target population, rising awareness levels for cancer detection, and increasing government initiatives in this region enabling the achievement of the largest market share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Technology
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Technology outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Oncology Based Molecular Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Oncology Based Molecular Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Oncology Based Molecular Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 4.2. Oncology Based Molecular Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Breast Cancer
    • 4.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Prostate Cancer
    • 4.4.1. Prostate cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Colorectal Cancer
    • 4.5.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cervical Cancer
    • 4.6.1. Cervical cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Liver Cancer
    • 4.7.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Lung Cancer
    • 4.8.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Blood Cancer
    • 4.9.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Kidney Cancer
    • 4.10.1. Kidney cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Other Cancer
    • 4.11.1. Others cancer market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Oncology Based Molecular Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 5.2. Oncology Based Molecular Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Instruments
    • 5.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Reagents
    • 5.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Oncology Based Molecular Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 6.2. Oncology Based Molecular Diagnostics Market: Technology Movement & Market Share Analysis, 2022 & 2030
  • 6.3. PCR
    • 6.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. In situ hybridization
    • 6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. INAAT
    • 6.5.1. INAAT market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Chips and microarrays
    • 6.6.1. Chips and microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Mass spectrometry
    • 6.7.1. Mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Sequencing
    • 6.8.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. TMA
    • 6.9.1. TMA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Oncology Based Molecular Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Oncology Based Molecular Diagnostics Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. U.K.
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bayer AG
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. BD
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Cepheid
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Agilent Technologies, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Danaher
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Hologic, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Qiagen
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. F. Hoffmann-La Roche Ltd.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Siemens
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Sysmex
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives